Markets:

Overview

News

Currencies

International

Treasuries

Exact Sciences Corporation - Common Stock (NQ:EXAS)

101.67 -0.07 (-0.07%)

Streaming Delayed Price Updated: 11:21 AM EST, Dec 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Exact Sciences Corporation - Common Stock

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

21 22 Next >

2 Stocks to Invest $500 In and Hold For 10 Years ↗

June 22, 2023

Both companies have outperformed the market over the past year.

Via The Motley Fool

Exact Sciences Stock Is Trading Higher: What's Going On? ↗

June 21, 2023

Exact Sciences Corp (NASDAQ: EXAS) shares are trading higher Wednesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for

Via Benzinga

Why Exact Sciences Stock Is Moving Higher After Hours ↗

June 20, 2023

Exact Sciences Corp (NASDAQ: EXAS) shares are rising in extended trading Tuesday after the cancer screening and diagnostics company said its Cologuard test demonstrated 94% sensitivity for

Via Benzinga

Why Exact Sciences Stock With 219% Growth Could Surge Again ↗

June 20, 2023

The company is trying to top its own success in colon cancer screening.

Via Investor's Business Daily

10 Health Care Stocks With Whale Alerts In Today's Session ↗

June 20, 2023

Via Benzinga

3 Revolutionary Companies With Trillion-Dollar Potential ↗

June 14, 2023

These are just a few of the trillion-dollar potential companies to put on your radar screen for the second half.

Via InvestorPlace

What 8 Analyst Ratings Have To Say About Exact Sciences ↗

June 07, 2023

Via Benzinga

1 Unstoppable Growth Stock to Buy and Hold for 10 Years ↗

June 07, 2023

This company is finding success in fighting one of the deadliest illnesses.

Via The Motley Fool

Why Exact Sciences Stock Roared Higher This Week ↗

May 11, 2023

The cancer diagnostic company's Q1 report was full of good news for shareholders.

Via The Motley Fool

This Analyst With 87% Accuracy Rate Sees Around 16% Upside In Home Depot - Here Are 5 Stock Picks For Last Week From Wall Street's Most Accurate Analysts ↗

June 12, 2023

The S&P 500 settled higher on Friday, surpassing the 4,300 level for the first time since August. The index also recorded gains for four weeks in a row.

Via Benzinga

Why Top 2% Stock Exact Sciences Is On An Eight-Month Hot Streak — And Nearing A Profit-Taking Zone ↗

June 08, 2023

The colon cancer screening market is vast, and underserved. Exact Sciences wants to change that.

Via Investor's Business Daily

Cathie Wood Is Buying the SEC Lawsuit Dip in Coinbase (COIN) Stock ↗

June 07, 2023

Coinbase and the crypto industry at large is at war with regulators. But Cathie Wood is still buying shares of COIN stock.

Via InvestorPlace

Cathie Wood Onto 'Next Thing' In AI After ARK's Nvidia Exit: What's On Her Radar? ↗

May 31, 2023

Via Benzinga

3 High-Flying Cathie Wood Stocks That Are Up Over 50% This Year ↗

May 25, 2023

Is it too late to buy these rebounding stocks?

Via The Motley Fool

Expert Ratings for Exact Sciences ↗

May 11, 2023

Via Benzinga

Why Shares of Exact Sciences Rose on Wednesday ↗

May 10, 2023

The diagnostic testing company announced strong first-quarter earnings.

Via The Motley Fool

Exact Sciences (EXAS) Q1 2023 Earnings Call Transcript ↗

May 09, 2023

EXAS earnings call for the period ending March 31, 2023.

Via The Motley Fool

MarketBeat Week in Review – 5/15 - 5/19

May 20, 2023

Investors are battling stagflation as they wait for a recession, and the MarketBeat team continues to help you understand where to find opportunities

Via MarketBeat

Topics Economy Electric Vehicles

3 AI Stocks That Famed Investor Cathie Wood Is Betting On ↗

May 16, 2023

Exact Sciences will look to leverage AI to revolutionize its industry. Here are some other Cathie Wood AI stocks to consider too.

Via InvestorPlace

Exact Sciences Serves Investors Exactly What They Wished For

May 15, 2023

Diagnostic and cancer test products provider Exact Sciences Corp. (NASDAQ: EXAS) saw its shares spike over 17% on its Q1 2023 earnings results. The

Via MarketBeat

3 Personalized Medicine Stocks to Buy for Long-Time Returns ↗

May 15, 2023

Personalized medicine is the future of medicine. Here are three personalized medicine stocks to invest in so you don't miss out.

Via InvestorPlace

A Bull Market Is Coming: 1 Supercharged Growth Stock to Buy Hand Over Fist Before It Soars 164%, According to Wall Street ↗

May 14, 2023

This stock has been crushed by macroeconomic headwinds but could rebound big time if analysts are right.

Via The Motley Fool

Cathie Wood's Flagship ARK ETF Marks 5-Day Winning Streak — Outperforming Nasdaq, FAANG In May ↗

May 11, 2023

Cathie Wood's flagship fund Ark Innovation ETF (ARCA: ARKK) marked a five-day winning streak on Wednesday for the first time since January, as a lower-than-expected U.S.

Via Benzinga

Exact Sciences Guidance Beat Street View, Analyst Says Company Fires All Cylinders ↗

May 10, 2023

Exact Sciences Corp's (NASDAQ: EXAS) Q1 revenues increased 24% Y/Y to $602 million, beating the average Wall Street esti

Via Benzinga

Upstart, Compass, RingCentral And Other Big Stocks Moving Higher On Wednesday ↗

May 10, 2023

U.S. stocks traded mixed, with the Dow Jones dropping around 70 points on Wednesday. Here are some big stocks recording gains in today’s session.

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For May 10, 2023 ↗

May 10, 2023

Via Benzinga

A New Groundbreaking Tool to Detect Colon Cancer Earlier

May 10, 2023

A novel blood test for detecting colon cancer, the third most lethal type of cancer in the US, has been created. The Colorectal Cancer Screening Blood Test can identify cancer at early stages. This...

Via PressReach

EXAS Stock Earnings: Exact Sciences Beats EPS, Revenue Estimates ↗

May 09, 2023

EXAS stock posted Q1 results that include a loss per share of 42 cents and revenue that was much better than analysts expected.

Via InvestorPlace

Exact Sciences Posts Its 11th Consecutive Sales Beat As It Targets 'The Most Preventable' Cancer ↗

May 09, 2023

The company sells Cologuard, a test to screen for colon cancer.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For May 5, 2023 ↗

May 05, 2023

Via Benzinga

< Previous 1 2

...

10 11 12 13 14 15 16 17 18

...

21 22 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

Exact Sciences Corporation - Common Stock (NQ:EXAS)

All News about Exact Sciences Corporation - Common Stock

Starting at $3.75/week.

Subscribe Today